“In November 1999, the Company sold 578,704 shares of Common Stock from treasury to Nelson Bunker Hunt for an aggregate cash price of $250,000 (or $0.43 per share) in a private placement to an accredited investor pursuant to the exemption from registration provided by Section 3(b) and Rule 504.”
“In January 2000, the Company sold 1,813,272 shares of Common Stock from treasury for an aggregate cash price of $750,000 (or $0.413 per share) in a private placement to Nelson Bunker Hunt, an accredited investor pursuant to the exemption from registration provided by Section 3(b) and Rule 504.”
These transactions pre-date the loan agreement from the recent 8K filing.
“HEMCO Onshore LLC loaned CYTOGENIX, INC., the sum of Two Hundred Fifty Thousand Dollars ($250,000.00) on or about April 6, 2001. The principal amount was repaid in full on July 11, 2001 (the "Transaction");…”